MedTrace Logo

NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study

NCT06956703 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2025-05-29

No results posted yet for this study

Summary

The goal of this observational study is to learn about the comparisons of inflammatory markers between IBD and non-IBD (control) participants.

The main question it aims to answer is:

Are there differences in inflammatory markers between IBD and non-IBD (control) participants.

Conditions

Sponsors & Collaborators

  • Nottingham University Hospitals NHS Trust

    collaborator OTHER

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Gordon Moran Professor · University of Nottingham

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-12
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06956703 on ClinicalTrials.gov